author-photo

Jon Armstrong

AstraZeneca

48

Papers

2252

Citations

Citation Trend

Filter By

Papers (38) Sort By

Journal Conference Others

P48.21 Population Pharmacokinetics and Exposure-Response with Durvalumab Plus Platinum-Etoposide in ES-SCLC: Results from CASPIAN

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
CASPIAN: OS results from a randomised Phase III study of first-line Durvalumab ± Tremelimumab plus chemotherapy in ED-SCLC: OS-Ergebnisse von CASPIAN, einer randomisierten Phase-III-Studie zur Erstlinientherapie von Durvalumab ± Tremelimumab + Chemotherapie beim Extensive Stage kleinzelligen Lungenkarzinom (ES-SCLC)

2020
Show All
- Source
- Cite
- Save
Citations (0)
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (49)
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial

2019 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (117)
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (92)
PL02.11 Overall Survival with Durvalumab Plus Etoposide-Platinum in First-Line Extensive-Stage SCLC: Results from the CASPIAN Study

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (11)
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (47)
Interdisciplinary Senior Design Project to Develop a Teaching Tool: Filament Extruder

2018
Show All
- Source
- Cite
- Save
Citations (0)
1042ODurvalumab for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Preliminary results from a single-arm, phase 2 study

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (23)
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

2016 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (184)